Global Biosimilars Market Predicted to Double by 2030 as Major Biologic Patents Expire and Healthcare Systems Seek Sustainable Cost-Saving Solutions
The pharmaceutical world is currently facing a "patent cliff" of historic proportions, as many of the best-selling biological drugs in history lose their market exclusivity. This has opened the floodgates for the biosimilars market—highly similar versions of original biological medicines that offer the same clinical benefits at a significantly lower price point. Unlike generic versions of...
0 Commentarii 0 Distribuiri 103 Views 0 previzualizare